High preoperative CA 15-3 concentrations predict adverse outcome in node-negative and node-positive breast cancer: study of 600 patients with histologically confirmed breast cancer.
about
CA 15-3 is predictive of response and disease recurrence following treatment in locally advanced breast cancerDo serum biomarkers really measure breast cancer?Serum sonic hedgehog (SHH) and interleukin-(IL-6) as dual prognostic biomarkers in progressive metastatic breast cancer.A tumor specific antibody to aid breast cancer screening in women with dense breast tissueMultiplexed cancer biomarker detection using quartz-based photonic crystal surfaces.CA 15-3 cell lines and tissue expression in canine mammary cancer and the correlation between serum levels and tumour histological grade.Elevated levels of preoperative CA 15-3 and CEA serum levels have independently poor prognostic significance in breast cancer.Protein glycosylation in cancer.Nomograms for Predicting the Prognostic Value of Pre-Therapeutic CA15-3 and CEA Serum Levels in TNBC Patients.Usefulness of serum CA 15.3 and histopathological prognostic indices in breast cancerCorrelation study of Carcino Embryonic Antigen & Cancer Antigen 15.3 in pretreated female breast cancer patientsElevated preoperative serum cancer antigen 15.3 levels are associated with reduced disease-free survival: a single-institution experience.Highly glycosylated tumour antigens: interactions with the immune system.Electroanalytical and surface plasmon resonance sensors for detection of breast cancer and Alzheimer's disease biomarkers in cells and body fluids.Breast cancer circulating biomarkers: advantages, drawbacks, and new insights.Serum tumour markers as a diagnostic and prognostic tool in Libyan breast cancer.The single nucleotide polymorphism +936 C/T VEGF is associated with human epidermal growth factor receptor 2 expression in Moroccan breast cancer women.CA15.3, CEA and LDH in dogs with malignant mammary tumors.Plasma TuM2-PK correlates with tumor size, CRP and CA 15-3 in metastatic breast carcinomas; short versus long term follow up study of the Egyptian breast cancer patients.Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy.Biomarker Studies in Early Detection and Prognosis of Breast Cancer.A cross-sectional study of tumor markers during normal and high-risk pregnancies.Prognostic role of CA15.3 in 7942 patients with operable breast cancer.CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patients.Paradox CA 15-3 increase in metastatic breast cancer patients treated with everolimus: a change of paradigm in a case series.CA 15-3 serum levels in patients with ductal breast carcinoma: relationship with clinicopathological parameters and tumor markers.Inhibitory Effect of Viola odorata Extract on Tumor Growth and Metastasis in 4T1 Breast Cancer Model.Clinicopathological and Prognostic Significance of Cancer Antigen 15-3 and Carcinoembryonic Antigen in Breast Cancer: A Meta-Analysis including 12,993 Patients.Elevated pre-surgical CA15-3: does it predict the short-term disease-free survival of breast cancer patients without distant metastasis?
P2860
Q33256427-0E28E9F7-F277-462F-BB9E-0787CB9A8EE7Q33454967-4D60084B-2F40-4C42-AE7C-832B73A70301Q33686729-EBB7813C-851A-4B30-AFF6-53160A374972Q33849708-5421A7DA-F567-4450-B47E-20356375577DQ34093465-8DE58594-833C-496B-B9A9-C6A95D9C4C2DQ34315017-135FB10F-0BDC-4F9B-8DF3-4A0686C1631AQ34646288-EBDA2ACD-7FFF-4C04-8C3B-A80B014D4611Q35413473-9B13276C-0CF5-4EA6-B421-F1DF5C2A6E9DQ36113248-2C00E5D0-F7B0-4D34-95D2-29F17ACC55AAQ36265759-4530B769-AD84-451C-A2A8-C7C90E443138Q36266095-5B434E81-6940-402E-9138-89BE1159D1F8Q37593523-82D9577A-8B54-49E8-A271-12172777FAB6Q37832274-31753922-2F04-40B4-994F-84A3DFB7EBDAQ38193833-0BE05613-2924-45C8-9A60-F599F309BDBAQ38573871-CE1E3C01-827C-4697-A64F-F0D894271D6AQ38991031-2B61DE9E-0F8A-48FC-94E4-532F4C2AA0C5Q39378690-3F0246DF-73B1-42A5-8729-0C5376E12850Q43462217-901B71B5-79AF-4520-B93D-0D205F97D202Q46489215-CF12AF4F-E096-40AD-9243-1829A9540698Q47962581-94583790-8123-43F9-8135-2A7D44F3C350Q49544412-66961C4C-2AF9-4B1F-A251-51B265167DAFQ50574071-371A775C-FB3A-4BA4-85B9-1444009A01E8Q50995298-C7124FB8-C616-4825-BDA2-2F5F3A94A000Q52849107-04C8E5D5-7BCE-41AA-AC08-96D776B49C2AQ53766709-E7A36C08-2F13-4B9E-B946-2650B2FAF433Q54559227-005D88A1-A917-4085-80FA-8FBEA9AE805EQ54935887-789EDEF6-45C0-41C6-8655-6D3F003342F4Q55036428-BF31AD54-6204-4F10-9D23-1918E6965DFBQ55447627-962FCFBF-63D3-4C97-B616-E94477509AA4
P2860
High preoperative CA 15-3 concentrations predict adverse outcome in node-negative and node-positive breast cancer: study of 600 patients with histologically confirmed breast cancer.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
High preoperative CA 15-3 conc ...... cally confirmed breast cancer.
@ast
High preoperative CA 15-3 conc ...... cally confirmed breast cancer.
@en
High preoperative CA 15-3 conc ...... cally confirmed breast cancer.
@nl
type
label
High preoperative CA 15-3 conc ...... cally confirmed breast cancer.
@ast
High preoperative CA 15-3 conc ...... cally confirmed breast cancer.
@en
High preoperative CA 15-3 conc ...... cally confirmed breast cancer.
@nl
prefLabel
High preoperative CA 15-3 conc ...... cally confirmed breast cancer.
@ast
High preoperative CA 15-3 conc ...... cally confirmed breast cancer.
@en
High preoperative CA 15-3 conc ...... cally confirmed breast cancer.
@nl
P2093
P1433
P1476
High preoperative CA 15-3 conc ...... cally confirmed breast cancer.
@en
P2093
Arnold D K Hill
Enda McDermott
John Crown
Michael J Duffy
Niall O'Higgins
Rachel Keane
P304
P356
10.1373/CLINCHEM.2003.025288
P407
P577
2004-01-15T00:00:00Z